OpportunityTitle: DoD FY15 Neuromusculoskeletal Injuries Award
Description: The FY15/16 JPC-8/CRMRP Neuromusculoskeletal Injuries Research Award (NMSIRA) is intended to support preclinical research and clinical trials on the reintegration after injury, functional utility of assistive devices related to the human-device interface, secondary health effects following severe extremity injury, and optimizing rehabilitation and device prescription for patients with neuromusculoskeletal injury. To meet the intent of the award mechanism, applications must specifically address one or more of the FY15/16 JPC-8/CRMRP NMSIRA Focus Areas listed below. Applications proposing research outside of the Focus Areas listed below should not be submitted in response to this Program Announcement/Funding Opportunity. - Limited capability to assess and facilitate the optimal restoration of physical and psychosocial reintegration following neuromusculoskeletal injury Lack of efficacious social support strategies Limited innovative technologies for interconnectivity Lack of demonstrable methods and technologies to assist and promote lifelong wellness and improved quality of life Limited validated methods that assess and facilitate effective return to desired real-world functional performance - Current assistive technology, including prosthetic and orthotic, characteristics that limit patient interaction, usability and durability Lack of proprioceptive and other sensory inputs that inhibit functional use and safety Lack of intuitive user intent control for functional use of assistive devices Lack of device interoperability between available and future components that limits functional potential of multi-joint systems Lack of human-device interface to address limb health, comfort, and function - Limited ability to predict, identify, and reduce secondary health effects that develop after primary neuromusculoskeletal injury Inability to determine factors that predict development and successful treatment of osteoarthritis, low back pain, or other musculoskeletal conditions Limited intervention strategies to diminish risk of falls Limited intervention strategies to decrease risk of fractures Limited strategies to prevent chronic comorbidities such as obesity, cardiovascular disease, and diabetes - Limited understanding of the optimal treatment strategies and sequence of progression throughout the rehabilitation process following neuromusculoskeletal injury, to include sprains and strains Inadequate evidence to determine the optimal dose, timing, frequency, duration, setting, and use of innovative rehabilitative techniques to minimize impairments, maximize function and performance, and/or achieve optimal quality of life - Inadequate measures for standardized assessment of relevant activity performance and participation Lack of validated metrics that effectively predict function following neuromusculoskeletal injury Limited number of validated metrics that effectively quantify changes that result from rehabilitation or provision of novel technologies Lack of quantifiable and functional objective standards for discharge from clinical care
GrantorContactEmailDescription: CDMRP Help Desk
GrantorContactText: CDMRP Help Desk &lt;br/&gt;Phone: 301-682-5507